44. Wegener granulomatosis Clinical trials / Disease details
Clinical trials : 98 / Drugs : 108 - (DrugBank : 28) / Drug target genes : 22 - Drug target pathways : 81
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04944524 (ClinicalTrials.gov) | July 1, 2021 | 22/6/2021 | Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA | Randomized Trial of Tofacitinib Versus Methotrexate for Maintenance Therapy in Granulomatosis With Polyangiitis | Granulomatosis With Polyangiitis | Drug: Tofacitinib;Drug: Methotrexate | Shanghai Zhongshan Hospital | NULL | Recruiting | 18 Years | 75 Years | All | 66 | Phase 4 | China |